Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000235797 is annotated as a pseudogene related to the ARP3 actin-related protein 3 homolog ACTR3, which means it is a non-functional DNA sequence similar to part of the ACTR3 gene but does not produce a functional protein product[5]. There is no evidence this pseudogene has a biological role, is a therapeutic target, or interacts with any drugs. Its naming reflects similarity to the functional gene ACTR3 but it does not contribute to actin cytoskeleton dynamics or any known cellular process. The entry may be the result of automated annotation or partial sequence similarity and should not be selected as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of ARP3 actin-related protein 3 homolog ACTR3.